Jenna Bush Hager and her husband, Henry Chase Hager, are parents to three kids. Here's everything to know about Jenna Bush Hager's children: Mila, Poppy and Hal.

RAHWAY, N.J., June 23, 2025--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced positive topline results from the Phase 3 HYPERION study evaluating WINREVAIR ...

Roche said in a statement that the experimental antibiotic zosurabalpin, jointly developed with Harvard University, would be tested against acinetobacter baumannii, relying on a new mode of action ...

For the first time in nearly two decades, JB Hager can sleep in. Hager, who spent the past two years hosting the morning show on Austin Radio Network’s Classic 105.3, has left the station.

Novocure NVCR recently announced positive top-line results from its pivotal Phase 3 PANOVA-3 trial, evaluating Tumor Treating Fields (TTFields) therapy in combination with gemcitabine and nab ...

Company to host conference call and webcast today, October 10, at 9:00 am EDT/3:00 pm CEST Company announces updated Phase 1b clinical data on ACTengine® IMA203 targeting PRAME in 28 heavily ...

Atea Pharmaceuticals announced the ongoing enrollment in its Phase 3 C-BEYOND trial evaluating the combination of bemnifosbuvir and ruzasvir for the treatment of hepatitis C virus (HCV). Positive ...

Let’s look at the 3 biggest Social Security myths and what we can expect in the future because of DOGE. Myth No. 1: Social Security W ill Go Bankrupt Fact : Social Security will not go bankrupt.

Trontinemab 3.6 mg/kg reduced amyloid below 24 centiloids in 81% of participants after 28 weeks, with mild ARIA-E cases in <5% of patients. Roche's Elecsys pTau181 plasma test showed potential to ...

On The Kelly Clarkson Show, the Stronger singer, 41, discussed weight struggles with the co-host of Today With Hoda & Jenna and also admitted that she 'loves losing weight'.

Key takeaways: Patients who received 4D-150 3E10 vg/eye experienced an 8.4 letter increase in BCVA. 4DMT is progressing to a phase 3 trial for 4D-150 3E10 vg/eye.

The DEEp SEA Study (LP352-302) is a global Phase 3 double-blind, placebo-controlled clinical trial to evaluate the efficacy of bexicaserin in Dravet syndrome as assessed by countable motor ...